Imlunestrant joins elacestrant (Orserdu) as the only FDA-approved oral therapies for ESR1 -mutant breast cancer. In contrast ...

The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Inluriyo ...

Paris, France - The US Food and Drug Administration (FDA) has told Sanofi-Aventis that its cannaboid-1 (CB1) receptor blocker rimonabant is "approvable" as a weight-loss drug but not as a ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) ...

Often administered to cancer patients alongside chemotherapy in the form of an IV, Leucovorin, is now being explored as a ...